ANIX
Price
$2.92
Change
-$0.12 (-3.95%)
Updated
Feb 4 closing price
Capitalization
97.47M
36 days until earnings call
Intraday BUY SELL Signals
GLUE
Price
$19.53
Change
-$1.40 (-6.69%)
Updated
Feb 4 closing price
Capitalization
1.49B
35 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANIX vs GLUE

Header iconANIX vs GLUE Comparison
Open Charts ANIX vs GLUEBanner chart's image
Anixa Biosciences
Price$2.92
Change-$0.12 (-3.95%)
Volume$275.71K
Capitalization97.47M
Monte Rosa Therapeutics
Price$19.53
Change-$1.40 (-6.69%)
Volume$1.12M
Capitalization1.49B
ANIX vs GLUE Comparison Chart in %
ANIX
Daily Signal:
Gain/Loss:
GLUE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ANIX vs. GLUE commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIX is a Hold and GLUE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (ANIX: $2.92 vs. GLUE: $19.53)
Brand notoriety: ANIX and GLUE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANIX: 75% vs. GLUE: 62%
Market capitalization -- ANIX: $97.47M vs. GLUE: $1.49B
ANIX [@Biotechnology] is valued at $97.47M. GLUE’s [@Biotechnology] market capitalization is $1.49B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIX’s FA Score shows that 0 FA rating(s) are green whileGLUE’s FA Score has 1 green FA rating(s).

  • ANIX’s FA Score: 0 green, 5 red.
  • GLUE’s FA Score: 1 green, 4 red.
According to our system of comparison, GLUE is a better buy in the long-term than ANIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIX’s TA Score shows that 3 TA indicator(s) are bullish while GLUE’s TA Score has 5 bullish TA indicator(s).

  • ANIX’s TA Score: 3 bullish, 3 bearish.
  • GLUE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GLUE is a better buy in the short-term than ANIX.

Price Growth

ANIX (@Biotechnology) experienced а -3.63% price change this week, while GLUE (@Biotechnology) price change was -7.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.41%. For the same industry, the average monthly price growth was +1.41%, and the average quarterly price growth was +32.47%.

Reported Earning Dates

ANIX is expected to report earnings on Mar 13, 2026.

GLUE is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (-2.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLUE($1.49B) has a higher market cap than ANIX($97.5M). GLUE YTD gains are higher at: 24.554 vs. ANIX (-6.410). GLUE has higher annual earnings (EBITDA): 16.8M vs. ANIX (-11.67M). GLUE has more cash in the bank: 391M vs. ANIX (15.2M). ANIX has less debt than GLUE: ANIX (204K) vs GLUE (40.2M). GLUE has higher revenues than ANIX: GLUE (182M) vs ANIX (0).
ANIXGLUEANIX / GLUE
Capitalization97.5M1.49B7%
EBITDA-11.67M16.8M-69%
Gain YTD-6.41024.554-26%
P/E RatioN/A61.09-
Revenue0182M-
Total Cash15.2M391M4%
Total Debt204K40.2M1%
FUNDAMENTALS RATINGS
ANIX: Fundamental Ratings
ANIX
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
4

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANIXGLUE
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 15 days ago
83%
Bullish Trend 3 days ago
89%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 11 days ago
89%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 7 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ANIX
Daily Signal:
Gain/Loss:
GLUE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PANHF1.88N/A
N/A
Ping An Healthcare & Technology Co Ltd.
SVJTY21.90N/A
N/A
Severstal PAO
CJAX3.55N/A
N/A
COJAX OIL & GAS CORP.
CGMLF1.39-0.11
-7.33%
Chalice Mining Ltd.
GELEF0.13-0.02
-10.39%
GRAPHANO ENERGY LTD

ANIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIX has been loosely correlated with VTGN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIX jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIX
1D Price
Change %
ANIX100%
-3.95%
VTGN - ANIX
57%
Loosely correlated
-3.20%
TPST - ANIX
56%
Loosely correlated
-1.24%
LEGN - ANIX
56%
Loosely correlated
-0.06%
BCAB - ANIX
55%
Loosely correlated
+11.06%
ENTX - ANIX
55%
Loosely correlated
-2.44%
More

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been closely correlated with STRO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLUE jumps, then STRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-6.69%
STRO - GLUE
68%
Closely correlated
+0.40%
ACET - GLUE
68%
Closely correlated
-3.51%
GLSI - GLUE
67%
Closely correlated
-3.62%
ERAS - GLUE
67%
Closely correlated
+6.19%
TERN - GLUE
66%
Closely correlated
-6.39%
More